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OBJECTIVE — To review interventions with adherence-promoting components and docu-
ment their impact on glycemic control via meta-analysis.
RESEARCH DESIGN AND METHODS — Data from 15 studies that met the following
criteria were subjected to meta-analysis: 1) randomized, controlled trial, 2) study sample in-
cludedyouthaged19years,3)youthhadtype1diabetes,4)studyreportedresultsonglycemic
control; and 5) study reported use of adherence- or self-management–promoting components.
RESULTS — The15studiesincluded997youthwithtype1diabetes.Themeaneffectsizefor
pre- to posttreatment change for the intervention versus control group comparison was 0.11
(95% CI 0.01 to 0.23). This is a small effect, demonstrating very modest improvements in
glycemic control. However, analysis for the pre- to posttreatment effects for the intervention
group alone did show signiﬁcant variability [Q(14)  33.11; P  0.05]. Multicomponent
interventions, those that targeted emotional, social, or family processes that facilitate diabetes
management, were more potent than interventions just targeting a direct, behavioral process
(e.g., increase in blood glucose monitoring frequency).
CONCLUSIONS — Interventions that focus on direct, behavioral processes and neglect
emotional, social, and family processes are unlikely to have an impact on glycemic control;
multicomponent interventions showed more robust effects on A1C. Future clinical research
should focus on reﬁning interventions and gathering more efﬁcacy and effectiveness data on
health outcomes of the pediatric patients treated with these interventions.
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I
nterventions with the aim of promot-
ing diabetes management are rooted in
the assumption that better adherence
to diabetes management leads to better
glycemic control. A recent meta-analysis
in pediatric type 1 diabetes conﬁrmed the
link between adherence and glycemic
control (1), supporting past research and
practice guidelines documenting the crit-
ical nature of adherence (2,3). Further, it
is well documented that the achievement
of better glycemic control confers re-
duced risk of acute and long-term com-
plications of type 1 diabetes (4–6).
Interventions with adherence-
promoting components typically target
direct, behavioral processes involved in
diabetes management or the indirect pro-
cesses that facilitate management; some
interventions target both. Interventions
may target the increase or improvement
of knowledge and skills needed to effec-
tively carry out a speciﬁc behavioral task.
For example, these interventions target
the promotion of blood glucose monitor-
ing (BGM), insulin administration, and
the coordination of those tasks with di-
etary intake and physical activity. Other
interventions with adherence-promoting
components may target the nature and
qualityoffamilycommunication(7)oran
individual’s coping skills (8,9) as they re-
late to diabetes management. In other
words,thereisanattempttointegrateand
promote the multiple layers involved in
effective diabetes management (10,11).
Interestingly, no matter the type of inter-
vention or targeted process, there is often
a unifying “measuring stick” to determine
thesuccessoftheseadherence-promoting
interventions: glycemic control.
In 2006, Winkley et al. (12) pub-
lished a meta-analysis on psychological
treatments for individuals with type 1 di-
abetes. The pediatric interventions were
moderately successful (i.e., effect size of
0.46) in promoting psychological out-
comes (e.g., reduction of distress); how-
ever, the mean effect size for glycemic
control improvement was 0.35. This
translated to a reduction in glycated he-
moglobin of 0.48% across the 10 ran-
domized, controlled trials included. The
authors concluded that there is evidence
ofamodestbeneﬁtofpsychologicalinter-
ventions for children and adolescents
with type 1 diabetes; however, signiﬁcant
work remains, given the variability in ef-
fects across studies and the lack of highly
potent psychological treatments for im-
proved glycemic control.
Considering the ﬁndings from Win-
kley et al. and their challenge to develop
more potent psychological interventions,
we were interested in determining
whether existing interventions that in-
clude adherence-promoting components
would fare better with regard to improv-
ingglycemiccontrol.Thatwasnotanaim
of the study of Winkley et al. Thus, the
aims of the current meta-analysis were to
document the effect of interventions with
adherence-promoting components on
glycemic control and to detail the impli-
cations for clinical research and practice
ofthemosteffectiveinterventionstodate.
We hypothesized that interventions with
adherence-promoting components
would demonstrate larger effects than
previous ﬁndings (12), given their direct
targetingofbehavioralprocessesinvolved
in diabetes management as well as facili-
tators (e.g., emotional, social, and family
processes) of effective management.
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METHODS
Search strategy and study selection
A literature search of PubMed (1994–
April 2009) and Scopus (1994–April
2009)wasconductedusingcombinations
of relevant keywords associated with pe-
diatrictype1diabetes,adherence-orself-
management–promoting interventions,
and glycemic control. The term type 1 di-
abetes was separately paired with each of
the terms designating a pediatric popula-
tion (children, adolescents, pediatric). Each
resultant search combination was paired
with an indicator of an adherence-
promoting intervention (e.g., adherence,
compliance, blood glucose monitoring inter-
ventions)andanindicatorofglycemicout-
comes (glycemic control, A1C). The results
ofthesesearcheswerethencross-checked
and overlapping citations were removed.
In addition, we reviewed several recent
reviews and meta-analyses that included
pediatric type 1 diabetes studies (12,13).
Studies were included if they met the fol-
lowing criteria: 1) study was a random-
ized, controlled trial, 2) individuals in the
study sample had type 1 diabetes, 3)
study sample included youth aged 19
years, 4) study reported results on adher-
ence and glycemic control; and 5) study
reported using an intervention with ad-
herence-promoting components.
Study coding and analysis of
reliability
We categorized intervention type as di-
rect or combined. Direct interventions
were those that focused entirely (or al-
most entirely) on direct, behavioral pro-
cesses. For example, an intervention that
targeted an increase in the frequency of
BGM and provided education or training
on this topic was considered a direct in-
tervention. Combined interventions fo-
cused on one or several behavioral tasks,
but the emphasis of the intervention was
on promoting coping or problem-solving
skills or a family process involved in dia-
betes management. For example, a com-
bined intervention may have targeted an
increase in BGM adherence but was also
focused on identifying and resolving bar-
riers to improving BGM adherence. We
also calculated the percentage of the in-
tervention that explicitly targeted adher-
ence promotion. For example, a study
included in this meta-analysis (14) pro-
vided a description of the intervention as
wellasanextensivetabledetailingsession
objectives and components. Three raters
(K.K.H., J.M.R., and C.M.P.) separately
determined the percentage of the infor-
mation described that focused on adher-
ence promotion (e.g., education and skill
development for adherence tasks and
overcoming barriers to adherence). This
was done for each study included in the
meta-analysis. We also coded the control
group as either “standard care” in which
thecontrolgrouponlyreceivedtheirstan-
dardcareinthediabetesclinicoras“stan-
dard care plus controlled variable” (e.g.,
attention, technological device, or service
access).
In addition, two authors (J.M.R. and
C.M.P.) coded studies across 10 charac-
teristics of the sample (year of publica-
tion, mean age, percent female, percent
ethnic minority, mean duration of type 1
diabetes,samplesize[total,experimental,
and control], mean A1C at baseline and
follow-up[experimentalandcontrol],de-
livery format of the intervention [group
versusindividual],timetofollow-up,and
statistics reported for adherence and
A1C). Time to follow-up was deﬁned as
the posttreatment time point designated
by the authors as the primary focus of the
analysis. This was either the posttreat-
ment effect or the ﬁrst follow-up effect,
typically within 6 months of the end of
treatment. Finally, we reversed the va-
lence of the effect size to be consistent
with typical health promotion interven-
tions.Inotherwords,apositiveeffectsize
showed that the A1C value was reduced:
positive health promotion. A negative ef-
fect size in this meta-analysis indicates a
worsening of glycemic control. The dou-
ble-entereddatawerethencomparedand
coefﬁcients(forcategoricalvariables)or
intraclass correlations (for interval vari-
ables) were calculated.
Primary and secondary analyses
We were primarily interested in the mag-
nitude of the effect size for change in gly-
cemic control from pre- to posttreatment
fortheinterventiongroupversusthecon-
trol group. To arrive at this, we ﬁrst cal-
culated an effect size for 1) pre- to
posttreatmentchangefortheintervention
group and 2) pre- to posttreatment
change for the control group. Then, we
calculated change scores for the pre- to
posttreatmentinterventionversuscontrol
comparison using an approach similar to
that described by Lipsey and Wilson (15)
and Winkley et al. (12). Speciﬁcally, the
mean change was divided by the pooled
SDofthetwogroupsineachstudy.Itwas
necessary to proceed with these steps to
not only test the primary treatment effect
but also to be sure the studies were ade-
quately controlled (i.e., there was no
change in the control groups). We also
examinedtheassociationamongstudyef-
fect size, characteristics of the sample,
time to follow-up, and the rated percent-
age of adherence promotion in the
intervention.
Statistical analysis
We used the analytic approach described
in Lipsey and Wilson (15) and completed
analysesinSAS(SASInstitute,Cary,NC).
When calculating the mean effect size
across studies, we used a weighted least
squaresapproachinwhicheacheffectsize
wasweightedbytheinverseofitsvariance
(16). This accounts for variability across
individual observations (i.e., studies)
while considering the size of the sample.
Speciﬁcally, the mean effect size, its SE,
and 95% CI were calculated. Homogene-
ityanalyses(16)wereconductedtodeter-
mine whether the mean effect size was
accurately predicted by each individual
effectsize.Homogeneityanalysesprovide
a fuller understanding of similarities and
differencesamongthestudiesincludedin
the meta-analysis. We calculated the Q
statistic and determined its statistical sig-
niﬁcance. Signiﬁcant Q values indicate
rejection of the null hypothesis of homo-
geneity (i.e., there is heterogeneity in
study effect sizes).
RESULTS
Search results and coding reliability
Our search identiﬁed 27 studies; how-
ever, upon further review, 12 studies did
not meet our inclusion criteria. These 12
studies were excluded because they were
not randomized, controlled trials (n 
10), only a small fraction of the sample
was aged 19 years (n  1), or no data
were provided (nor could be obtained via
contact with authors) on A1C values (n 
1).Thus,weidentiﬁed15studiesthatmet
our inclusion criteria (7,8,10,11,14,17–
26).Codingofthestudydesign,interven-
tion components, and categories of
interestineachstudywerecompletedand
 and intraclass correlation coefﬁcients
were all 1.00.
Study characteristics
Table 1 displays the characteristics of the
15 studies. Most studies were conducted
in the U.S.; one study was conducted in
the U.K. (25) and another in India (22).
Study sample sizes ranged from 22 to
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ies was 997. All studies reported recruit-
ing the study sample from the larger
pediatric diabetes clinic population, sug-
gestive of a convenience sample. How-
ever, two studies reported an inclusion
criterion of “poor” glycemic control indi-
cated by a certain A1C threshold (e.g.,
8.5%) (11,18). The average age of the
pooled samples was 13.55  2.23 years.
All but two studies reported the percent-
age of female participants; the average
Table 1—Characteristics of studies in meta-analysis
First
author
Year
(ref.)
Sample
size
Mean age in
years (range) Type of intervention*
Dose of
intervention
(time)†
%
intervention
targeting
adherence‡
Type of control
group
No.
weeks to
follow-up
Effect
size§
Anderson 1999 (10) 55 12.70 (10–15) Combined; delivered
in clinic; individual
families
4 (1-h) 80 Standard care 52.00 0.55
Brown 1997 (17) 59 No mean (8–16) Direct; diabetes video
game; individual
play at home
6 months of
access to
game
80 Video game: no
diabetes
content
26.00 0.07
Cook 2002 (14) 53 14.60 (13–18) Combined; delivered
in groups;
problem-solving
6 (2-h) 100 Standard care 26.00 0.10
Ellis 2005 (11) 127 13.25 (10–17) Combined; individual
multisystemic
therapy
3 per week/
for 6 months
70 Standard care 30.00 0.10
Grey 2000 (8) 75 14.20 (12–20) Combined; delivered
in groups; coping
skills
6 weekly  10
monthly
(1h )
25 Standard care 52.00 0.49
Howe 2005 (18) 54 12.40 (3–17) Direct; individual
family instruction,
then phone calls
12 weekly
calls  3
bimonthly
calls
25 Standard care 26.00 0.09
Kumar 2004 (19) 40 13.60 (8–18) Direct; diabetes
motivational game,
individual home
play
Access for 4
weeks
80 PDA only 15.00 0.22
Laffel 2003 (20) 100 12.10 (8–17) Combined; delivered
in clinic; individual
families
4 (1-h) 90 Standard care 52.00 0.39
Marrero 1995 (21) 106 13.30 (no range) Direct; individual
instruction; home
uploads of BGM
26 calls 
download
of BGM
80 Standard care 52.00 0.07
Matam 2000 (22) 40 18.25 (15–22) Combined; individual
sessions;
problem-solving
15 (1-h)
sessions
100 Standard care 13.00 0.40
McNabb 1994 (23) 22 9.86 (8–12) Combined; delivered
in groups;
family-focused
6 (1-h) 50 Standard care 12.00 0.05
Nansel 2007 (24) 78 13.80 (11–16) Combined; individual
families;
problem-solving
6 (1-h) 100 Standard care 
educational
booklet
26.00 0.18
Viner 2003 (25) 41 13.15 (10–17) Combined; delivered
in groups;
problem-solving
6 (1-h) 90 Standard care 21.00 0.59
Wysocki 2000 (7) 79 14.30 (12–17) Combined; individual
sessions; BFST
10 (1-h) 15 Standard care 13.00 0.05
Wysocki 2006 (26) 68 14.17 (11–16) Combined; individual
sessions; BFST-D
12 (1-h) 20 Standard care 26.00 0.21
*Type of intervention is deﬁned as combined (direct and indirect processes targeted) or direct (direct processes only). †Dose of intervention refers to the number
of sessions. ‡Percent intervention targeting adherence was determined by review of articles by three authors (K.K.H., J.M.R., and C.M.P.). §Effect size is the pre- to
posttreatment,interventionvs.controlgroupeffectsize;positiveeffectsizesreﬂectimprovementinglycemiccontrol(i.e.,healthpromotion)andnegativeeffectsizes
reﬂect deterioration in glycemic control. The methods of Viner et al. (25) suggest potential selection bias; recruited individuals were from a pool of assessed
individuals. It is unclear whether they were randomly drawn in the assessment study. BFST, behavioral family systems therapy (D, diabetes).
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reported the race/ethnicity of the sample;
the average proportion of nonwhite indi-
viduals in those samples was 27.0%.
However,therewasconsiderablevariabil-
ity in that the studies ranged from 4 to
74% inclusion of minority participants.
Veryfewstudiesreportedindicatorsofso-
cioeconomic status and family structure
(e.g., proportion of families with two
caregivers in home); thus, we did not col-
lect data on these variables. Time to fol-
low-up ranged from 12 to 52 weeks with
an average length of 29.5 weeks. Of note,
only ﬁve studies were less than 26 weeks.
Attrition rates were available for nine of
the studies; it ranged from 3.4 to 13.3%.
Diabetes-speciﬁc variables consis-
tentlyreportedinstudiesweredurationof
type 1 diabetes and glycemic control.
Across the 15 studies, mean duration of
type 1 diabetes ranged from 2.7 to 8.7
years; average across the studies was
5.89  3.60 years. The mean A1C for the
experimental group was 9.61  1.83%
(range 7.8–11.9%) at baseline and
9.17  1.53% (range 7.5–12.3%) at fol-
low-up. The mean A1C for the control
group at baseline was 9.75  1.83% and
at follow-up was 9.70  1.76%.
Mean effect sizes
The mean effect size for the pre- to post-
treatment change in glycemic control for
the intervention group was 0.13, with in-
dividual study effects ranging from
0.50 to 0.99. Overall, there was modest
improvement for individuals in the
pooled intervention group. The mean ef-
fect size for the pre- to posttreatment
change in the control group was 0.01,
withindividualstudyeffectsrangingfrom
0.24 to 0.32. This effect size indicates
that glycemic control did not change over
time for the pooled control group.
The mean effect size for pre- to post-
treatmentchangefortheinterventionver-
sus control group comparison was 0.11
(95% CI 0.01 to 0.23). Effects ranged
from 0.55 to 0.59, and ﬁve were nega-
tive (i.e., deterioration in glycemic con-
trol). The mean effect size of 0.11 meets
conventional standards for a small effect
and indicates that there was very modest
improvement in glycemic control over
time. Effect sizes and conﬁdence intervals
for the individual studies are presented in
Fig. 1. The association between the mean
effect size for pre- to posttreatment
changefortheinterventionversuscontrol
group and time to follow-up was not
signiﬁcant (r  0.07, P  0.05). The
correlation between the pre- to posttreat-
ment intervention versus control effect
size and whether the intervention tar-
geted direct, behavioral processes alone
or had combined targets was signiﬁcant
(Spearmanr0.56,P0.03).Thisﬁnd-
ing indicates that multicomponent inter-
ventions (i.e., those that targeted direct
and indirect processes together) were as-
sociated with larger effects on glycemic
control. Finally, because only a small
number of studies were delivered in a
group format and all others were done
individually, we did not conduct a com-
parison based on intervention delivery
format.
Factors associated with mean effect
size
Homogeneity analysis of the pre- to post-
treatment intervention versus control
group comparison revealed homogeneity
acrossthe15studies[Q(14)18.40;P
0.05].Inotherwords,therewaslittlevari-
ability in effects across these randomized,
controlled trials. However, analysis for
the pre- to posttreatment effects for the
intervention group alone did show signif-
icant variability [Q (14)  33.11, P 
0.05]. This result illustrates that even
though studies were adequately con-
trolled,theinterventionsproduceddiffer-
ent magnitudes of A1C change. We
hypothesizedthatthisvariabilitycouldbe
attributed to the percentage of the inter-
vention targeting adherence promotion.
Inotherwords,interventionsthatfocused
almost entirely on adherence promotion
should do better than those that included
components other than adherence pro-
motion.However,thecorrelationwasnot
statistically signiﬁcant (P  0.05).
CONCLUSIONS — Results of this
meta-analysis show that the mean effect
size for the pre- to posttreatment change
Figure 1—Effect sizes and conﬁdence intervals for the individual studies.
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was 0.11. Whereas the mean change of
A1Cvaluesfrombaselinetofollow-upfor
youth in the intervention groups of these
studies was 9.6 to 9.2%, variability in ef-
fectsandtheweightingofeffectsbasedon
sample size translates to just a modest
0.20% reduction in A1C values. Overall,
this meta-analysis shows that the pooled
effect on glycemic control of these 15 in-
terventions was very modest.
Before identifying the implications of
these meta-analytic results, we want to
highlight the context of these ﬁndings as
well as the positive aspects of these re-
sults. This meta-analysis included 14
studies not reviewed in the meta-analysis
of Winkley et al. (12); the only overlap-
ping study was by Wysocki, Harris, and
colleagues (26). Thus, this meta-analysis
extends the current evidence base for in-
terventions deployed in pediatric type 1
diabetes. Interestingly, the interventions
that we described as “adherence-
promoting interventions” fared worse
overall than the psychological interven-
tions in the prior meta-analysis. Specif-
ically, the mean effect size in this
meta-analysis was 3 times smaller than
that reported by Winkley et al. (12). One
reason for this may be our inclusion of
interventions targeting direct, behavioral
processes because these studies conferred
little beneﬁt on glycemic control. In our
meta-analysis,theinterventionsthatfared
the best were those that were multicom-
ponentandaddressedboththedirectand
indirect processes involved in diabetes
management. For example, the coping
skills training program of Grey et al. (8)
produced a pre- to posttreatment inter-
vention versus control effect size of 0.49.
This program trains groups of youth with
type 1 diabetes to “increase the[ir]
ability…to cope with problems that they
face on a day-to-day basis and to be more
effective in achieving therapeutic goals”
(8). Their inclusion of diabetes-speciﬁc
social scenarios may have served to but-
tress the development of general coping
skills. At least three other studies
(20,22,25) were similarly multicompo-
nentandhadeffectsizesof0.40.Two
other studies (24,26) also contained sim-
ilar components and had effect sizes of
0.20. Overall, these interventions seem
to be exemplars for the type of interven-
tions that carry considerable beneﬁt for
improvement in glycemic control.
On the other hand, the mean effect
size of this meta-analysis provides a so-
bering look at the current state of inter-
ventions with adherence-promoting
components if improvement in glycemic
control is the measuring stick. Why is the
mean effect size so small and why do only
a few interventions produce considerable
beneﬁt on glycemic control? This meta-
analysis can rule out several answers to
that question. First, the percentage of the
intervention directly targeting adherence
promotion does not seem to be a factor.
Whatappearsimportantiswhetherornot
the indirect processes are targeted in the
intervention.Ifso,thebeneﬁtonglycemic
control should be more favorable. As
noted nearly two decades ago by Johnson
and her colleagues (2,27), adherence is
just one of the multiple factors that inﬂu-
ence glycemic control. Perhaps the pri-
mary focus on adherence behaviors and
the neglect of other areas related to glyce-
mic control (social support, family rela-
tionships, coping, and problem-solving
skills) is what drove the present ﬁndings.
Second, and related to the ﬁrst point, the
dose of the intervention does not appear
to be a factor. A sizable effect on glycemic
control was observed in the study by
Laffel, Anderson, and colleagues (20),
which included approximately four clin-
ic-based intervention sessions across the
year plus support from the “Care Ambas-
sador” in scheduling appointments and
working with clinic staff. The dose in this
study was considerably less than that in
other time- and resource-heavy interven-
tions (11,26), both with more modest ef-
fectsonglycemiccontrol,aswellasthatin
an earlier iteration of the Anderson and
Laffelfamily-basedintervention(10).Ad-
mittedly, the unmeasured competing
needs of the participants across these
studies may not make this a fair compar-
ison.Nevertheless,doseappearstobeless
important than the inclusion of multiple
components with the aim of facilitating
adherence promotion. Third, there was
no association between time to follow-up
and effect sizes. Because these studies
were controlled and there was little
changeinglycemiccontrolforthecontrol
participants, simply stopping the deterio-
ration of glycemic control that is so com-
monly seen across late childhood and
adolescence (28–30) was not enough to
demonstrate statistical signiﬁcance. Al-
though there is certainly clinical signiﬁ-
cance in preventing further deterioration,
theinterventionsthatreducedA1Cvalues
stood out and the length of time to the
follow-up assessment did not matter.
The primary implication of these
meta-analytic results is that there is con-
siderable work left to be done to make a
signiﬁcant impact on glycemic outcomes.
However, after a thorough review of the
most potent interventions, we conclude
there is no need to start over. For exam-
ple, we should learn from the interven-
tions that produce reductions in A1C
values approaching 1.0% (e.g., from 9.5
to 8.5%). These should be replicated and
deployedinclinicstofurtherdemonstrate
their effectiveness. We should also obtain
abetterunderstandingofhowmuchcost-
savings these interventions provide. For
example, to what extent do they reduce
acute and long-term medical complica-
tions that show up in extra medical and
emergency department visits? Further,
what are the direct costs to the clinics in
terms of stafﬁng and supplies and will in-
surance companies reimburse for these
services? Likewise, an evaluation of psy-
chosocialfunctioning(e.g.,health-related
quality of life) will also provide critical
information about the broader impact of
these interventions.
At the same time efforts are made to
documenteffectiveness,theinterventions
demonstrating modest effects on glyce-
miccontrolmaybeneﬁtfromtheaddition
of other components and then a reexam-
ination of their efﬁcacy. For example, the
most efﬁcacious interventions target pro-
cesses other than direct, behavioral pro-
cesses; they target the critical emotional,
social, and family factors that youth with
type 1 diabetes face on a daily basis. By
focusing more so on these facilitators of
adherence, these interventions may dem-
onstrate improved efﬁcacy. Considered
together, the collection of effectiveness
dataonthemostpotentinterventionsand
adapting and reﬁning less potent inter-
ventions will push the ﬁeld closer to pro-
viding evidence-based care in pediatric
diabetes clinics.
The results of this meta-analysis and
our recommendations should be consid-
ered in the context of several limitations.
First, a meta-analysis pools studies and
cannot account for differing methodolo-
gies and sampling strategies (31). Even
with randomization and control condi-
tions, the heterogeneity in individual
effect sizes among the interventions in-
cluded highlights that fact that there is
considerable variability in the potency of
these interventions. The extent to which
that variability is related to the sampling
methodologyandfeaturesofstudydesign
cannot be ascertained through meta-
analysis. Second, the teams of investiga-
tors from these 15 studies may not have
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primary mechanism to change glycemic
control. The primary targets of the inter-
ventions (i.e., hypothesized mechanism
to promote change in A1C) may have
been broader than adherence promotion
andencompassedfamily,system,oremo-
tional variables. We simply identiﬁed in-
terventions with adherence-promoting
components and may not be fully charac-
terizing the whole treatment package.
Third, and related to the last point, our
team made decisions about the coding of
multiple variables (time to follow-up, treat-
ment components, and percentage of ad-
herence promotion). Although we were
guided by past research and clinically
guided assumptions, others may have
coded these variables in a different manner.
Fourth, other variables that inﬂuence
glycemic control (e.g., growth, puberty,
and insulin regimen) were not examined
in this study, yet there is compelling evi-
dence for their contribution to subopti-
mal glycemic outcomes (29,32,33).
Further, there are inconsistent reports of
sociodemographic variables such as so-
cioeconomic status and family structure
across these studies. In fact, some do not
provide any data on these characteristics.
Given the links between these variables
and glycemic outcomes (34–36), future
reports should include indicators of
socioeconomic status such as family in-
come, educational achievement, occupa-
tionalstatus,orfullsocioeconomicscales.
Arelatedlimitationisthatfewofthestud-
ies targeted “high-risk” youth, those who
consistently demonstrate high A1C val-
ues and have fewer resources and sup-
port. These youth and their families may
respond better to higher doses of treat-
ment and attention to the multiple sys-
tems in which they attempt to manage
diabetes. Indeed, there are compelling
data on the effectiveness of these types of
programs with these high-risk youth
(37,38). Finally, we did not include an
examination of changes in adherence in
the included studies. Given the data that
adherence is linked to glycemic control
(1) and a focus on optimizing glycemic
controlinpracticeguidelines(3),wewere
primarily concerned with understanding
whether these interventions alter glyce-
mic outcomes. Although we do not sus-
pect this to be the case, it is possible that
some interventions included in this meta-
analysisimprovedadherencesigniﬁcantly
while not altering glycemic control.
In sum, this review and meta-analysis
of interventions focused on adherence
promotion in pediatric type 1 diabetes
emphasizes two points. First, it is likely
that glycemic control will not improve if
interventions focus on direct, behavioral
processes involved in diabetes manage-
ment and neglect emotional, social, and
family processes. Second, we need to
implement the effective programs in pe-
diatric diabetes clinics and obtain effec-
tiveness data. It is important that we
better understand the costs and savings
from a monetary perspective and also
from the perspective of health outcomes
of the pediatric patients cared for in these
clinics.
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